Found 4348 articles for: ""
Onychomycosis: Classification and Diagnosis
January 2004 | Volume 3 | Issue 1 | Original Article | 51 | Copyright © January 2004
Onychomycosis is a common infection of the nail predominantly caused by anthropophilic dermatophytes, and to a lesser extent by yeasts (Candida species) and non-dermatophyte molds. The treatment of o...
Read MorePhotorejuvenation with Intense Pulsed Light: Results of a Multi-Center Study
January 2004 | Volume 3 | Issue 1 | Original Article | 41 | Copyright © January 2004
This multi-center study evaluating the role of Intense Pulsed Light (IPL) in the non-ablative rejuvenation of Type I and Type II photoaged skin study was conducted in order to evaluate the clinical e...
Read MoreImpact of Efalizumab on Psoriasis-Specific Patient-Reported Outcomes
January 2004 | Volume 3 | Issue 1 | Original Article | 27 | Copyright © January 2004
The objective of this study was to document the disease burden associated with moderate to severe plaque psoriasis, and assess the impact of efalizumab psoriasis treatment in improving patient-report...
Read MoreTopical Treatment of Actinic Keratosis with Fluorouracil: Is Irritation Associated with Efficacy?
January 2004 | Volume 3 | Issue 1 | Original Article | 21 | Copyright © January 2004
Actinic keratoses (AKs) are common dysplastic epidermal lesions that share clinical, histologic, and molecular features with squamous cell carcinoma. Therapeutic options include destructive modalitie...
Read MoreRedefining Clinical Response in Psoriasis: Targeting the Pathological Basis of Disease
January 2004 | Volume 3 | Issue 1 | Original Article | 13 | Copyright © January 2004
Psoriasis is a chronic inflammatory disease of the skin that can have a major effect on patient quality of life. Conventional psoriasis treatments, often identified empirically, fail to meet the clin...
Read MoreBotox Reverses the Signs of Photoaging
December 2003 | Volume 2 | Issue 6 | Original Article | 683 | Copyright © December 2003
Improvement of Acanthosis Nigricans on Isotretinoin and Metformin
December 2003 | Volume 2 | Issue 6 | Case Reports | 677 | Copyright © December 2003
Acanthosis nigricans (AN) is an eruption of hyperpigmented, velvety thickened patches, often with papillomatosis, that occurs symmetrically on any body site but most commonly at the axillae, neck, gr...
Read MoreReticulate and Stellate Acral Pigmentation Associated with Systemic Lupus Erythematosus and High Titers of Circulating Anticardiolipin Antibodies: A Possible Association with Acral Microlivedo
December 2003 | Volume 2 | Issue 6 | Case Reports | 674 | Copyright © December 2003
A Hispanic man with a twenty-eight year history of systemic lupus erythematosus (SLE) and a high titer of anticardiolipin IgG antibodies was noted to have reticulate and stellate acral pigmentation. ...
Read MoreImiquimod for the Treatment of Bowen's Disease and Invasive Squamous Cell Carcinoma
December 2003 | Volume 2 | Issue 6 | Case Reports | 669 | Copyright © December 2003
Topical imiquimod is an immune response modifier FDA approved for the treatment of anogenital warts. Recent studies have reported its effectiveness in the treatment of some types of basal cell carcin...
Read MoreGeneralized Granuloma Annulare in a Patient with Adult Onset Diabetes Mellitus
December 2003 | Volume 2 | Issue 6 | Case Reports | 666 | Copyright © December 2003
Granuloma annulare is a benign idiopathic disorder, which affects the dermis. Several reports have demonstrated an association between granuloma annulare and diabetes mellitus. We report the case of ...
Read MoreDoxycycline-Induced Photo-onycholysis
December 2003 | Volume 2 | Issue 6 | Case Reports | 662 | Copyright © December 2003
An uncommon manifestation of phototoxicity, photo-onycholysis results in the separation of the distal nail from the nail bed. Photoonycholysis may follow the use of various medications or may occasio...
Read MoreFixed Drug Eruption to Ibuprofen in Daughter and Father
December 2003 | Volume 2 | Issue 6 | Case Reports | 658 | Copyright © December 2003
Fixed drug eruption (FDE) is a common cutaneous reaction which may be seen in reaction to several medications. The usual etiologic agents associated with FDE are phenazones, sulfonamides, and tetracy...
Read MoreComparing Therapy Costs for Physiciian Treatment of Warts
December 2003 | Volume 2 | Issue 6 | Original Article | 649 | Copyright © December 2003
To compare the cost of several common modalities used to treat non-genital warts in immunocompetent patients, we identified studies published in English using standard search strategies and evaluated...
Read MoreEffect of PTU on IL-12 and IL-10 in Psoriasis
December 2003 | Volume 2 | Issue 6 | Original Article | 645 | Copyright © December 2003
Propylthiouracil (PTU), an antithyroid thioureylene with immunomodulatory properties, has been shown to be effective in the therapy of patients with plaque psoriasis. The mechanism of action of antit...
Read MoreCompatibility of Desoximetasone and Tacrolimus
December 2003 | Volume 2 | Issue 6 | Original Article | 640 | Copyright © December 2003
The physical and chemical compatibility of desoximetasone ointment 0.25% and tacrolimus ointment 0.1%, both widely used to treat atopic dermatitis, were determined. A 1:1 (w/w) mixture of desoximetas...
Read MorePhotodynamic Therapy for Molluscum Contagiosum Infection in HIV-Coinfected Patients: Review of 6 Patients
December 2003 | Volume 2 | Issue 6 | Original Article | 637 | Copyright © December 2003
Molluscum contagiosum, a viral disease of the skin, manifests as a smooth-surfaced, firm, and spherical papule with umbilication of the vertex. It commonly presents as multiple lesions, which may be ...
Read MoreShort Incubation PDT versus 5-FU in Treating Actinic Keratoses
December 2003 | Volume 2 | Issue 6 | Original Article | 629 | Copyright © December 2003
The efficacy of photodynamic therapy (PDT) using broad area treatment with 5-aminolevulinic acid (ALA) has not been compared to topical 5-fluorouracil (5-FU) in the treatment of actinic keratoses (AK...
Read MoreRemittive Effects of Intramuscular Alefacept in Psoriasis
December 2003 | Volume 2 | Issue 6 | Original Article | 624 | Copyright © December 2003
Alefacept is the first biologic agent approved for the treatment of chronic plaque psoriasis in the United States. Alefacept, administered intravenously (IV) or intramuscularly (IM), was found to be ...
Read MoreA Possible Role for Non-Ablative Radiofrequency in the Treatment of Rosacea
December 2003 | Volume 2 | Issue 6 | Original Article | 621 | Copyright © December 2003
Rosacea is a chronic disease characterized by redness, pimples, and thickened and inflamed skin. It affects both women and men, and does so primarily between the ages of 30 and 60. Daily interaction w...
Read MoreMultiple Fixed Drug Eruption with Interferon/Ribvirin Combination Therapy for Hepatitis
October 2003 | Volume 2 | Issue 5 | Case Reports | 570 | Copyright © October 2003
Interferon/ribavirin combination therapy is the treatment of choice for chronic hepatitis C virus (HCV) infection. Cutaneous reactions to interferon therapy, both local and distant from the injection...
Read More